好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An Open-Label, Nonrandomized, Prospective, Multicenter Study To Evaluate the Safety and Tolerability of Glatiramer Acetate 20 mg sc Once Daily in Patients with Severe Relapsing-Remitting Multiple Sclerosis That Have Discontinued Natalizumab after 12 to 18 Months Therapy. Preliminary Results
MS and Related Diseases
(-)
005
Authors/Disclosures
Silvia Rossi, MD No disclosure on file
Teresa Coelho, MD (Unidate Clinica de Paramoloidose Hospital) Dr. Coelho has nothing to disclose.
No disclosure on file
No disclosure on file
Caterina Motta Caterina Motta has nothing to disclose.
No disclosure on file
Valentina De Chiara, PhD No disclosure on file
No disclosure on file
No disclosure on file
Marco Salvetti, MD Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Dr. Salvetti has received research support from bms.
No disclosure on file